Shah Vinay
Insider CIK 1753078 · ADIL Chief Financial Officer · ARAV Chief Financial Officer · VRPX Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ADIL ADIAL PHARMACEUTICALS, INC | A Award | 2026-04-07 | 2026-04-09 | 17,325 | — | $0 | 17,325 | SEC↗ |
| ADIL ADIAL PHARMACEUTICALS, INC | A Award deriv | 2025-05-29 | 2025-06-02 | 9,000 | — | $0 | 9,000 | SEC↗ |
| ADIL ADIAL PHARMACEUTICALS, INC | A Award deriv | 2024-11-16 | 2024-11-18 | 40,000 | — | $0 | 40,000 | SEC↗ |
| VRPX Virpax Pharmaceuticals, In | A Award deriv | 2024-01-29 | 2024-01-31 | 112,000 | — | $0 | 112,000 | SEC↗ |
| VRPX Virpax Pharmaceuticals, In | A Award deriv | 2023-06-20 | 2023-08-16 | 100,000 | — | $0 | 100,000 | SEC↗ |
| VRPX Virpax Pharmaceuticals, In | A Award deriv | 2023-06-20 | 2023-06-21 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ARAV Aravive, Inc. | A Award deriv | 2022-01-24 | 2022-01-25 | 175,000 | — | $0 | 175,000 | SEC↗ |
| ARAV Aravive, Inc. | P Buy | 2021-06-29 | 2021-06-29 | 1,000 | $5.31 | $5.3K | 190,842 | SEC↗ |
| ARAV Aravive, Inc. | A Award deriv | 2021-01-25 | 2021-01-26 | 60,000 | — | $0 | 60,000 | SEC↗ |
| ARAV Aravive, Inc. | P Buy | 2020-12-04 | 2020-12-07 | 8,000 | $5.76 | $46.1K | 189,842 | SEC↗ |
| ARAV Aravive, Inc. | A Award deriv | 2020-01-22 | 2020-01-24 | 34,826 | — | $0 | 34,826 | SEC↗ |
| ARAV Aravive, Inc. | A Award deriv | 2019-02-28 | 2019-03-04 | 38,000 | — | $0 | 38,000 | SEC↗ |
| ARAV Aravive, Inc. | A Award deriv | 2018-10-12 | 2018-10-16 | 19,000 | — | $0 | 19,000 | SEC↗ |
| ARAV Aravive, Inc. | A Award deriv | 2018-10-12 | 2018-10-16 | 19,380 | — | $0 | 19,380 | SEC↗ |
| ARAV Aravive, Inc. | A Award deriv | 2018-10-12 | 2018-10-16 | 38,001 | — | $0 | 38,001 | SEC↗ |
| ARAV Aravive, Inc. | A Award deriv | 2018-10-12 | 2018-10-16 | 19,000 | — | $0 | 19,000 | SEC↗ |
| ARAV Aravive, Inc. | A Award | 2018-10-12 | 2018-10-16 | 178,606 | — | $0 | 178,606 | SEC↗ |